M.D. Sass LLC Has $72.44 Million Stock Position in Danaher Corporation $DHR

M.D. Sass LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 2.4% in the third quarter, Holdings Channel.com reports. The institutional investor owned 365,389 shares of the conglomerate’s stock after acquiring an additional 8,735 shares during the period. Danaher makes up 5.9% of M.D. Sass LLC’s portfolio, making the stock its 3rd largest holding. M.D. Sass LLC’s holdings in Danaher were worth $72,442,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Norges Bank bought a new stake in Danaher in the 2nd quarter worth approximately $1,979,503,000. Viking Global Investors LP boosted its stake in shares of Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after buying an additional 2,455,994 shares during the last quarter. Generation Investment Management LLP boosted its stake in shares of Danaher by 56.2% in the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after buying an additional 1,787,522 shares during the last quarter. Primecap Management Co. CA increased its position in Danaher by 924.2% during the second quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock valued at $244,815,000 after acquiring an additional 1,118,318 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in Danaher by 1.3% in the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after acquiring an additional 788,499 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 over the last quarter. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $215.70 on Friday. The company has a market capitalization of $152.36 billion, a price-to-earnings ratio of 42.80, a PEG ratio of 2.97 and a beta of 0.91. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock’s 50-day simple moving average is $229.81 and its 200-day simple moving average is $214.68. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.14 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is 25.40%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DHR. Argus set a $265.00 price target on Danaher in a research note on Wednesday, January 14th. Robert W. Baird set a $251.00 target price on shares of Danaher in a research report on Thursday, January 29th. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. The Goldman Sachs Group dropped their price target on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. Twenty research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $252.32.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.